Thanks to visit codestin.com
Credit goes to link.springer.com

Skip to main content
Springer Nature Link
Log in
Menu
Find a journal Publish with us Track your research
Search
Cart
  1. Home
  2. Diabetologia
  3. Article

Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study

  • Published: May 1997
  • Volume 40, pages 698–705, (1997)
  • Cite this article
Download PDF
Diabetologia Aims and scope Submit manuscript
Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
Download PDF
  • M. Greaves1,
  • R. G. Malia2,
  • K. Goodfellow2,
  • M. Mattock3,
  • L. K. Stevens4,
  • J. M. Stephenson4,
  • J. H. Fuller4 &
  • …
  • Complications Study Group EURODIAB IDDM1 
  • 656 Accesses

  • 58 Citations

  • Explore all metrics

Summary

The interrelationships between fibrinogen, von Willebrand factor, a marker of vascular endothelial cell damage, and serum lipids were explored in well-characterised subjects with insulin-dependent diabetes mellitus. The 2091 subjects were enrolled into a cross-sectional, clinic-based study of complications, from 16 European countries: the EURODIAB IDDM Complications study. The anticipated significant relationships between both plasma fibrinogen and plasma von Willebrand factor concentrations and age and glycaemic control, and between fibrinogen and body mass index, were noted. Fibrinogen, adjusted for age and glycated haemoglobin concentration, was also related to smoking habits and was higher in the quartiles with highest systolic and diastolic blood pressures. There was a clustering of vascular risk factors, with a positive relationship between plasma fibrinogen and serum triglyceride concentrations in both genders and between fibrinogen and total cholesterol in males. An inverse relationship between fibrinogen and high density lipoprotein cholesterol was also apparent in males. A prominent feature was a positive relationship between both fibrinogen and von Willebrand factor and albumin excretion rate (p < 0.001 and p < 0.003 respectively) in those with retinopathy but not in those without this complication. In view of previous observations on blood pressure and albuminuria in these subjects the findings are consistent with the hypothesis that microalbuminuria and increased plasma von Willebrand factor are due to endothelial cell perturbation in response to mildly raised blood pressure in subjects with retinopathy. Fibrinogen may also contribute to microvascular disease and its relationships to lipid vascular risk factors suggest a possible pathogenic role in arterial disease in diabetes. [Diabetologia (1997) 40: 698–705]

Article PDF

Download to read the full article text

Similar content being viewed by others

Assessment of multimedia-supported intervention in Muslim diabetic patients treated with insulin

Article 11 January 2016

Blood Viscosity, Glycemic Markers and Blood Pressure: A Study in Middle-Aged Normotensive and Hypertensive Type 2 Diabetics

Article 01 November 2018

Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study

Article Open access 17 August 2020

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.
  • Antiphospholipid syndrome
  • Coagulation Disorders
  • Diabetes
  • Dyslipidaemias
  • Type 2 diabetes
  • Vascular Diseases
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Author information

Authors and Affiliations

  1. Department of Medicine and Therapeutics, University of Aberdeen, Scotland, UK, , , , , , GB

    M. Greaves & Complications Study Group EURODIAB IDDM

  2. Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK, , , , , , GB

    R. G. Malia & K. Goodfellow

  3. Department of Chemical Pathology, UMDS, St. Thomas's Hospital, London, UK, , , , , , GB

    M. Mattock

  4. Department of Epidemiology and Public Health, University College, London, UK, , , , , , GB

    L. K. Stevens, J. M. Stephenson & J. H. Fuller

Authors
  1. M. Greaves
    View author publications

    Search author on:PubMed Google Scholar

  2. R. G. Malia
    View author publications

    Search author on:PubMed Google Scholar

  3. K. Goodfellow
    View author publications

    Search author on:PubMed Google Scholar

  4. M. Mattock
    View author publications

    Search author on:PubMed Google Scholar

  5. L. K. Stevens
    View author publications

    Search author on:PubMed Google Scholar

  6. J. M. Stephenson
    View author publications

    Search author on:PubMed Google Scholar

  7. J. H. Fuller
    View author publications

    Search author on:PubMed Google Scholar

  8. Complications Study Group EURODIAB IDDM
    View author publications

    Search author on:PubMed Google Scholar

Additional information

Received: 10 December 1996 and in revised form: 14 March 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greaves, M., Malia, R., Goodfellow, K. et al. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study. Diabetologia 40, 698–705 (1997). https://doi.org/10.1007/s001250050736

Download citation

  • Issue date: May 1997

  • DOI: https://doi.org/10.1007/s001250050736

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

  • Keywords Fibrinogen
  • von Willebrand factor
  • albuminuria
  • insulin-dependent diabetes mellitus
  • vascular disease.
Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Advertisement

Search

Navigation

  • Find a journal
  • Publish with us
  • Track your research

Discover content

  • Journals A-Z
  • Books A-Z

Publish with us

  • Journal finder
  • Publish your research
  • Language editing
  • Open access publishing

Products and services

  • Our products
  • Librarians
  • Societies
  • Partners and advertisers

Our brands

  • Springer
  • Nature Portfolio
  • BMC
  • Palgrave Macmillan
  • Apress
  • Discover
  • Your US state privacy rights
  • Accessibility statement
  • Terms and conditions
  • Privacy policy
  • Help and support
  • Legal notice
  • Cancel contracts here

132.145.61.108

Not affiliated

Springer Nature

© 2025 Springer Nature